Advertisement
(Photo: http://www.newscom.com/cgi-bin/prnh/20080617/NYTU025 )
(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )
The ARTISTE Solution is a linear accelerator engineered specifically forAdaptive Radiation Therapy (ART). Unique in design, ARTISTE is an integratedimaging and workflow solution that offers a comprehensive portfolio ofimage-guided and advanced treatment delivery protocols, including in-room CTimaging capabilities and a new multileaf collimator, 160 MLC(TM).
Advertisement
One of the first patients treated with ARTISTE was seen at DKFZ, where thelinear accelerator was used to administer radiotherapy for an inoperableesophagus tumor. "Treatment for this type of tumor demands a very complicatedradiotherapy approach," said Prof. Dr. Huber, head of the Radiation OncologyClinical Cooperation Unit at DKFZ. "Using ARTISTE's 160 MLC MultileafCollimator, we were able to significantly improve the precision of the dosedelivery, while protecting immediate surrounding healthy tissue."
That same week, several patients at MAASTRO Clinic were also treated usingARTISTE. A couple of challenging clinical cases included a metastasized tumorin the abdominal region and a patient with two separate metastases: one in thehead and neck region, and one in the knee cap.
"The advanced, high-end imaging capabilities of ARTISTE allow us to fullyintegrate all our Image-Guided Radiation Therapy (IGRT) and MAASTRO-developedDose-Guided Radiation Therapy (DGRT) methods in one clinical workflow.ARTISTE's imaging flexibility and simplified workflow help us to confidentlytreat proliferated tumors in a wide range of areas of the body," said BasNijsten, medical radiotherapy physicist in the Maastricht Radiation OncologyDepartment.
More recently, the first U.S. patients were treated with ARTISTE Solutionat the Baton Rouge General's Pennington Cancer Center. The first two patientswere treated for lung and prostate tumors, respectively, where ARTISTE's 2Dand 3D imaging allowed confirmation of tumor location and enabled more focusedand aggressive treatment, while helping spare organs at risk.
"With ARTISTE, Siemens is changing the way radiotherapy is delivered. Asthe first site in the U.S. with ARTISTE, our mission at Baton Rouge General'sPennington
Cancer Center is to combine our commitment to compassionate cancer carewith the latest, most advanced treatment technology," said Dr. WilliamRussell, medical director of Radiation Oncology at Pennington Cancer Center.
"This exciting milestone has come to fruition thanks to the clinicalcollaboration between Siemens, MAASTRO, DKFZ, and Baton Rouge General," saidHolger Schmidt, chief executive officer, Oncology Care Systems, SiemensMedical Solutions USA, Inc. "ARTISTE's unique integration of technologies andstreamlined workflow allows clinicians to truly customize patient treatment byproviding them the flexibility and means to confidently optimize treatment ona per-patient basis. It is an honor for us at Siemens to be part of thiscollaborative effort to help improve quality of care for cancer patientsaround the world. We are delighted to have 55 new ARTISTE orders since itsintroduction in the market last January."
The goal of Adaptive Radiation Therapy (ART) is to ensure the therapeuticdose is delivered precisely to the target, and healthy tissue is spared asplanned. To achieve this goal, it is necessary to image the patient just priorto treatment, verify that the patient p
